— Know what they know.
Not Investment Advice
Also trades as: DMP.DE (XETRA) · $vol 1M · 52D0.F (FSX) · $vol 0M

DMPHF OTC

Dermapharm Holding SE
1W: +0.0% 1M: +0.0% 3M: -10.0% YTD: +20.6% 1Y: +20.6% 3Y: +17.4%
$47.69
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 44 · $2.4B mcap · 11M float · 0.0000% daily turnover · Short 100% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
Oct 02, 2026
DCF
5
ROE
5
ROA
5
D/E
1
P/E
3
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. DMPHF receives an overall rating of A-. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-03 None ADDED
2026-09-30 EXISTED None
2026-09-26 None ADDED
2026-09-26 EXISTED None
2026-09-22 None ADDED
2026-09-19 EXISTED None
2026-09-15 None ADDED
2026-09-13 EXISTED None
2026-09-09 None ADDED
2026-09-05 EXISTED None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade B
Profitability
58
Balance Sheet
40
Earnings Quality
80
Growth
59
Value
—
Momentum
85
Safety
—
Cash Flow
64

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
5/9
✓ ✓ ✓ ✓ ✗ ✗ ✓ ✗ ✗
Beneish M-Score
-1.98
Unlikely Manipulator
Ohlson O-Score
-6.14
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BBB
Score: 58.1/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.64x
Accruals: -4.3%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. DMPHF scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. DMPHF's score of -1.98 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. DMPHF's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. DMPHF receives an estimated rating of BBB (score: 58.1/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). DMPHF's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
13.54x
PEG
0.35x
P/S
1.57x
P/B
3.46x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$26.85
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 13.5x earnings, DMPHF trades at a reasonable valuation. Graham's intrinsic value formula yields $26.85 per share, 78% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.760
NI / EBT
×
Interest Burden
0.727
EBT / EBIT
×
EBIT Margin
0.225
EBIT / Rev
×
Asset Turnover
0.541
Rev / Assets
×
Equity Multiplier
3.823
Assets / Equity
=
ROE
25.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. DMPHF's ROE of 25.6% is driven by financial leverage (equity multiplier: 3.82x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$114.04
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with DMPHF's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. DMPHF actually compounded EPS at 31.5% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. DMPHF trades at a premium to its adjusted intrinsic value of $114.04, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 13.5x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 961 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$47.69
Median 1Y
$46.91
5th Pctile
$25.62
95th Pctile
$85.71
Ann. Volatility
36.5%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 5.6% 13.7% 13.5% 17.4% 11.6% 9.7% 15.5% 16.0% 19.9% 17.0% 18.5% 18.8% 20.4% 20.9% 25.6% 25.65%
ROA 2.1% 3.7% 3.3% 4.4% 3.5% 2.6% 3.8% 4.2% 5.4% 4.8% 4.9% 5.5% 6.2% 6.6% 6.7% 6.71%
ROIC 4.4% 6.7% 6.4% 8.7% 7.2% 19.3% 30.9% 28.3% 9.6% 9.0% 9.7% 9.5% 10.3% 11.2% 13.0% 13.05%
ROCE 5.2% 7.7% 8.6% 11.5% 9.3% 9.1% 10.0% 10.8% 12.5% 11.2% 12.3% 12.3% 12.5% 12.7% 14.8% 14.80%
Gross Margin 68.4% 66.6% 59.4% 61.5% 58.5% 66.1% 62.8% 63.0% 66.5% 65.9% 67.7% 36.4% 33.6% 35.5% 33.4% 33.36%
Operating Margin 26.4% 26.4% 4.0% 18.0% 13.5% 21.8% 13.1% 21.2% 16.5% 19.8% 16.3% 22.0% 18.2% 23.1% 24.9% 24.92%
Net Margin 10.3% 15.5% -3.5% 8.7% -1.0% 14.5% 6.1% 10.4% 7.1% 11.0% 7.7% 14.0% 12.5% 14.8% 8.1% 8.14%
EBITDA Margin 31.5% 30.9% 17.1% 26.0% 8.1% 32.8% 17.9% 27.4% 24.9% 27.3% 24.3% 30.8% 28.7% 29.8% 33.0% 33.03%
FCF Margin 39.8% 29.9% 21.2% 20.7% 15.3% 11.9% 12.4% 13.1% 13.7% 11.0% 14.9% 14.2% 15.9% 18.7% 16.2% 16.21%
OCF Margin 43.5% 32.8% 24.6% 24.1% 18.9% 15.6% 16.1% 16.5% 17.0% 14.5% 18.3% 17.8% 19.5% 22.4% 20.3% 20.30%
ROE 3Y Avg snapshot only 20.02%
ROA 3Y Avg snapshot only 5.11%
ROIC 3Y Avg snapshot only 7.62%
ROIC Economic snapshot only 11.71%
Cash ROA snapshot only 10.72%
Cash ROIC snapshot only 15.92%
CROIC snapshot only 12.71%
NOPAT Margin snapshot only 16.64%
Pretax Margin snapshot only 16.32%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 16.53%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — 13.538
P/S Ratio — — — — — — — — — — — — — — — 1.573
P/B Ratio — — — — — — — — — — — — — — — 3.461
P/FCF — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — —
PEG Ratio snapshot only 0.345
Graham Number snapshot only $26.85
Leverage & Solvency
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.45 2.30 2.01 1.86 1.60 1.57 1.58 1.66 1.82 2.05 1.84 2.20 2.05 2.00 1.71 1.712
Quick Ratio 1.30 1.23 0.92 0.87 0.79 0.75 0.78 0.74 0.78 0.91 0.87 1.04 1.09 1.08 0.88 0.880
Debt/Equity 0.97 1.96 2.11 2.01 2.00 0.00 0.00 0.00 1.62 1.56 1.66 1.56 1.52 1.41 2.18 2.178
Net Debt/Equity 0.67 1.57 1.85 1.75 1.71 -0.20 -0.30 -0.21 1.42 1.37 1.39 1.33 1.22 1.06 1.81 1.814
Debt/Assets 0.37 0.52 0.52 0.51 0.50 0.00 0.00 0.00 0.47 0.47 0.47 0.48 0.48 0.46 0.52 0.521
Debt/EBITDA 5.65 5.98 4.68 3.55 4.51 0.00 0.00 0.00 3.19 3.42 3.30 3.25 3.24 3.13 3.23 3.230
Net Debt/EBITDA 3.89 4.79 4.11 3.09 3.84 -0.49 -0.67 -0.48 2.79 3.01 2.75 2.78 2.61 2.37 2.69 2.690
Interest Coverage 12.35 7.79 4.78 4.06 2.62 2.48 2.69 2.91 3.62 3.49 3.95 4.13 4.24 4.58 5.15 5.147
Equity Multiplier 2.66 3.73 4.06 3.96 4.01 3.73 4.00 3.64 3.44 3.31 3.51 3.26 3.18 3.08 4.18 4.178
Cash Ratio snapshot only 0.439
Debt Service Coverage snapshot only 7.004
Cash to Debt snapshot only 0.167
FCF to Debt snapshot only 0.164
Defensive Interval snapshot only 811.8 days
Efficiency & Turnover
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.21 0.28 0.41 0.54 0.64 0.52 0.53 0.55 0.56 0.55 0.54 0.55 0.54 0.53 0.54 0.541
Inventory Turnover 0.36 0.63 0.93 1.24 1.53 1.32 1.27 1.28 1.28 1.22 1.15 1.39 1.72 1.88 2.14 2.142
Receivables Turnover 3.00 5.78 7.94 9.37 12.16 9.75 10.32 9.50 12.38 9.35 10.26 9.17 11.07 8.80 9.31 9.310
Payables Turnover 1.63 2.47 3.97 4.82 6.12 4.65 5.07 4.90 4.63 4.15 4.17 5.12 6.02 6.32 7.46 7.462
DSO 122 63 46 39 30 37 35 38 29 39 36 40 33 41 39 39.2 days
DIO 1002 580 391 293 238 276 287 284 285 298 317 263 212 194 170 170.4 days
DPO 223 148 92 76 60 78 72 74 79 88 88 71 61 58 49 48.9 days
Cash Conversion Cycle 901 495 345 257 208 235 250 248 236 249 265 232 184 178 161 160.7 days
Fixed Asset Turnover snapshot only 3.568
Operating Cycle snapshot only 209.6 days
Cash Velocity snapshot only 6.056
Capital Intensity snapshot only 1.893
Growth (YoY)
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — 2.9% 84.2% 31.1% 1.2% 4.1% 5.8% 2.9% -0.9% -1.9% -1.6% 0.5% 0.49%
Net Income — — — — 1.1% -28.6% 18.4% -4.6% 82.4% 83.0% 29.1% 28.2% 16.4% 39.5% 36.9% 36.88%
EPS — — — — 1.1% -28.7% 18.2% -4.8% 82.7% 83.0% 30.0% 28.5% 16.7% 39.6% 48.0% 48.03%
FCF — — — — 50.9% -26.7% -23.2% -35.8% -6.6% -1.9% 23.2% 6.9% 13.4% 66.6% 9.3% 9.32%
EBITDA — — — — 1.6% 26.5% 4.8% -16.7% 28.2% 21.1% 24.5% 21.2% 5.6% 14.6% 18.0% 17.98%
Op. Income — — — — 1.4% 2.0% 11.4% -7.5% 18.6% 28.5% 14.2% 5.3% 2.8% 10.9% 19.4% 19.38%
OCF Growth snapshot only 11.40%
Asset Growth snapshot only 4.84%
Equity Growth snapshot only -11.89%
Debt Growth snapshot only 15.62%
Shares Change snapshot only -7.53%
Dividend Growth snapshot only 11.84%
Growth (CAGR)
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — 58.9% 24.3% 10.7% 10.66%
Revenue 5Y — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — 64.3% 22.1% 31.5% 31.51%
EPS 5Y — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — 64.3% 22.1% 27.9% 27.92%
Net Income 5Y — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — 52.6% 20.6% 15.5% 15.46%
EBITDA 5Y — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — 43.7% 6.7% -10.2% -10.21%
Gross Profit 5Y — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — 42.6% 13.3% 15.0% 14.96%
Op. Income 5Y — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — 17.0% 6.2% 1.1% 1.12%
FCF 5Y — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — 21.6% 9.5% 3.8% 3.84%
OCF 5Y — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — 16.0% 1.7% 1.9% 1.94%
Assets 5Y — — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — 9.3% 8.5% 0.9% 0.93%
Book Value 3Y — — — — — — — — — — — — 9.3% 8.5% 3.8% 3.77%
Dividend 3Y — — — — — — — — — — — — 1.1% 1.1% 4.0% 3.97%
Growth Quality
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — — — 0.79 0.83 0.83 0.06 0.62 0.66 0.70 0.700
Earnings Stability — — — — — — — — 0.98 0.27 0.97 0.60 0.97 0.69 0.95 0.948
Margin Stability — — — — — — — — 0.95 0.95 0.97 0.96 0.88 0.81 0.74 0.739
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.00 1.00 0.50 1.00 0.50 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence — — — — — — — — 0.50 0.50 0.88 0.89 0.93 0.84 0.85 0.852
Earnings Smoothness — — — — 0.30 0.67 0.83 0.95 0.42 0.41 0.75 0.75 0.85 0.67 0.69 0.689
ROE Trend — — — — — — — — 0.10 0.05 0.03 0.01 0.04 0.07 0.11 0.110
Gross Margin Trend — — — — — — — — -0.00 0.00 0.02 -0.04 -0.13 -0.20 -0.29 -0.293
FCF Margin Trend — — — — — — — — -0.14 -0.10 -0.02 -0.03 0.01 0.07 0.03 0.025
Sustainable Growth Rate 5.6% 13.7% 13.5% 17.4% 11.6% 9.7% 15.5% 7.6% 11.6% 9.2% 10.3% 10.9% 12.9% 13.8% 17.1% 17.08%
Internal Growth Rate 2.2% 3.8% 3.4% 4.6% 3.6% 2.7% 4.0% 2.1% 3.2% 2.7% 2.8% 3.3% 4.1% 4.5% 4.7% 4.68%
Cash Flow Quality
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 4.23 2.52 3.06 2.93 3.47 3.10 2.22 2.14 1.77 1.67 2.01 1.78 1.71 1.82 1.64 1.636
FCF/OCF 0.92 0.91 0.86 0.86 0.81 0.76 0.77 0.80 0.81 0.76 0.81 0.80 0.81 0.83 0.80 0.798
FCF/Net Income snapshot only 1.306
OCF/EBITDA snapshot only 0.664
CapEx/Revenue 3.7% 2.9% 3.3% 3.4% 3.6% 3.7% 3.6% 3.4% 3.2% 3.5% 3.4% 3.6% 3.6% 3.8% 4.1% 4.09%
CapEx/Depreciation snapshot only 0.505
Accruals Ratio -0.07 -0.06 -0.07 -0.09 -0.09 -0.05 -0.05 -0.05 -0.04 -0.03 -0.05 -0.04 -0.04 -0.05 -0.04 -0.043
Sloan Accruals snapshot only -0.037
Cash Flow Adequacy snapshot only 2.465
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — 2.35%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.88 $0.88 $0.88 $0.88 $0.91 $0.91 $0.91 $0.99 $0.88
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 52.3% 41.6% 45.7% 44.2% 42.2% 37.0% 33.9% 33.4% 33.39%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 30.8% 29.0% 36.1% 27.0% 29.8% 26.5% 22.4% 25.6% 25.56%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 52.3% 41.6% 45.7% 44.2% 42.2% 37.0% 33.9% 1.6% 1.57%
Div. Increase Streak — — — — — — — 0 0 0 0 1 1 1 1 0
Chowder Number — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.53 0.63 0.57 0.60 0.59 0.57 0.64 0.64 0.66 0.66 0.66 0.68 0.72 0.74 0.76 0.760
Interest Burden (EBT/EBIT) 0.92 0.87 0.79 0.75 0.65 0.63 0.73 0.75 0.79 0.78 0.75 0.77 0.79 0.81 0.73 0.727
EBIT Margin 0.21 0.24 0.18 0.18 0.14 0.14 0.15 0.16 0.18 0.17 0.19 0.19 0.20 0.21 0.22 0.225
Asset Turnover 0.21 0.28 0.41 0.54 0.64 0.52 0.53 0.55 0.56 0.55 0.54 0.55 0.54 0.53 0.54 0.541
Equity Multiplier 2.66 3.73 4.06 3.96 3.34 3.73 4.03 3.79 3.71 3.51 3.74 3.44 3.30 3.18 3.82 3.823
Per Share
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.56 $1.47 $1.30 $1.76 $1.15 $1.05 $1.54 $1.68 $2.11 $1.92 $2.00 $2.16 $2.46 $2.68 $2.96 $2.96
Book Value/Share $9.87 $10.78 $9.68 $10.14 $9.98 $10.81 $10.22 $10.82 $11.20 $11.85 $11.35 $12.08 $12.89 $13.78 $10.82 $10.76
Tangible Book/Share $-0.83 $-10.48 $-11.65 $-11.11 $-8.90 $-9.91 $-10.29 $-9.54 $-8.97 $-8.20 $-8.68 $-7.74 $-6.93 $-6.00 $-10.93 $-10.93
Revenue/Share $5.40 $11.32 $16.21 $21.49 $21.10 $20.85 $21.20 $21.70 $22.01 $22.06 $21.97 $21.56 $21.65 $21.73 $23.87 $23.85
FCF/Share $2.15 $3.39 $3.44 $4.45 $3.23 $2.48 $2.64 $2.85 $3.02 $2.44 $3.27 $3.05 $3.44 $4.06 $3.87 $3.46
OCF/Share $2.35 $3.72 $3.98 $5.18 $4.00 $3.26 $3.41 $3.59 $3.73 $3.20 $4.02 $3.84 $4.22 $4.88 $4.85 $4.44
Cash/Share $3.00 $4.21 $2.49 $2.65 $2.95 $2.18 $3.07 $2.30 $2.26 $2.19 $3.10 $2.73 $3.78 $4.72 $3.94 $3.95
EBITDA/Share $1.70 $3.53 $4.36 $5.74 $4.44 $4.46 $4.56 $4.77 $5.70 $5.40 $5.72 $5.79 $6.03 $6.19 $7.29 $7.29
Debt/Share $9.59 $21.10 $20.42 $20.36 $19.99 $0.00 $0.00 $0.00 $18.15 $18.47 $18.84 $18.82 $19.54 $19.38 $23.56 $23.56
Net Debt/Share $6.60 $16.89 $17.92 $17.71 $17.04 $-2.18 $-3.07 $-2.30 $15.90 $16.28 $15.75 $16.09 $15.76 $14.66 $19.62 $19.62
Academic Models
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — —
Piotroski F-Score 4 4 4 4 5 5 7 6 9 6 8 6 6 6 5 5
Beneish M-Score — — — — -2.88 -2.39 -3.01 -2.55 -2.66 -2.61 -2.54 -2.23 -1.96 -2.15 -1.98 -1.981
Ohlson O-Score snapshot only -6.138
Net-Net WC snapshot only $-19.06
EVA snapshot only $45933485.07
Credit
Metric Trend Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB
Credit Score 66.55 60.65 52.70 54.35 46.40 58.40 58.40 58.40 53.15 55.70 54.35 56.90 56.90 58.05 58.10 58.100
Credit Grade snapshot only 9
Credit Trend snapshot only 3.750
Implied Spread (bps) snapshot only 275.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms